Search

Your search keyword '"Beige J"' showing total 264 results

Search Constraints

Start Over You searched for: Author "Beige J" Remove constraint Author: "Beige J"
264 results on '"Beige J"'

Search Results

1. Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

2. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

4. Baroreflexaktivierungstherapie bei therapieresistenter Hypertonie: Empfehlungen der BAT-Konsensusgruppe zu Implantation und Nachsorge

5. The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease

6. Barorezeptorakivierungstherapie bei therapierefraktärer Hypertonie: Indikation und Patientenselektion: Empfehlungen der BAT-Konsensusgruppe 2017

10. Data sharing under the general data protection regulation: Time to harmonize law and research ethics?

11. Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?

16. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

18. Baroreflexaktivierungstherapie bei therapieresistenter Hypertonie

25. Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes

27. Characteristics of high- and low-risk individuals in the PRIORITY study:urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes

28. Characteristics of high‐ and low‐risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes

30. Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection. Recommendations of the BAT consensus group 2017

34. Reconstructive kidney surgery for organ-preserving therapy of renal tumors

36. No evidence of systemic CMV reactivation in chronic hemodialysis patients: a single centre experience

37. Beta-lactam continuous infusion therapy (BLACIT) compared to linezolid or vancomycin in the treatment of catheter-related Staphylococcus aureus blood-stream infections (CRBSI-SA) in hemodialysis patients – a retrospective analysis

38. Impact of preoperative TACE on incidences of microvascular invasion and long‐term post‐hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis

39. Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction

40. Serum levels of the adipokine adipocyte fatty acid binding protein are increased in chronic and acute renal dysfunction

41. Effect of UMOD genotype on long-term graft survival after kidney transplantation in patients treated with cyclosporine-based therapy

42. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease.

49. Le matériel et les exigences associées

Catalog

Books, media, physical & digital resources